POM-V Prescription Required

Utertab 2000 mg Intrauterine Tablet for Cattle

Active ingredient: Tetracycline Hydrochloride

Form

Tablet

Species

Cattle

Manufacturer

aniMedica GmbH

VMD MA No.

24745/4025

What it's used for

For treatment and prevention of post parturient disorders in cattle: for administration following retained foetal membranes and endometritis caused by path...

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Tetracycline Hydrochloride

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Utertab 2000 mg Intrauterine Tablet for Cattle — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 26 Mar 2026.

For treatment and prevention of post parturient disorders in cattle: for administration
following retained foetal membranes and endometritis caused by pathogens
susceptible to tetracycline as well as after severe obstetrical procedures (fetotomy,
caesarean section).

Intrauterine use.
Cows:
2 g tetracycline hydrochloride / cow / day
equivalent to 1 tablet / cow /day
Treat one to three times at intervals of 1 up to 2 days.

Unlimited Renewal: December 2022
AN: 02355/2022

Do not use in infections caused by pathogens resistant to tetracycline.
Do not use in known cases of hypersensitivity to the active substance or to any of the
excipients.
Do not use in severe kidney or liver disorders.

Occurrence of renal disorders is enhanced in dehydrated animals.
Tetracycline can cause damage to the liver.
Photodermatitis often occurs in areas of sparsely pigmented skin if these are
exposed to intensive sunlight.
Allergic reactions are rare.
In case of allergic or anaphylactic reactions, discontinue treatment immediately.
Allergic reactions can be treated parenterally with glucocorticoids and antihistamines.
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals treated displaying adverse reaction(s)
- common (more than 1 but less than 10 animals in 100 animals treated)
- uncommon (more than 1 but less than 10 animals in 1,000 animals treated )
- rare (more than 1 but less than 10 animals in 10,000 animals treated)
- very rare (less than 1 animal in 10,000 animals treated, including isolated reports).

None.

Unlimited Renewal: December 2022
AN: 02355/2022

Special precautions for use in animals
Whenever possible, the product should only be used based on susceptibility testing.
Official, national and regional antimicrobial policies should be taken into account
when the product is used. Milk from treated cows should not be fed to calves up to
the end of the milk withdrawal period, except during the colostral phase, due to
potential for selection of resistance in intestinal flora of calves.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
This product may cause sensitisation. Avoid direct contact with the skin or the
mucous membranes.
Gloves should be worn when handling the veterinary medicinal product.
Wash hands after use.

There is a potential antagonism between tetracyclines and antibiotics with
bactericidal action.

This veterinary medicinal product does not require any special storage conditions.

potential for selection of resistance in intestinal flora of calves.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
This product may cause sensitisation. Avoid direct contact with the skin or the
mucous membranes.
Gloves should be worn when handling the veterinary medicinal product.
Wash hands after use.
4.6 Adverse reactions (frequency and seriousness)
Occurrence of renal disorders is enhanced in dehydrated animals.
Tetracycline can cause damage to the liver.
Photodermatitis often occurs in areas of sparsely pigmented skin if these are
exposed to intensive sunlight.
Allergic reactions are rare.
In case of allergic or anaphylactic reactions, discontinue treatment immediately.
Allergic reactions can be treated parenterally with glucocorticoids and antihistamines.
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals treated displaying adverse reaction(s)
- common (more than 1 but less than 10 animals in 100 animals treated)
- uncommon (more than 1 but less than 10 animals in 1,000 animals treated )
- rare (more than 1 but less than 10 animals in 10,000 animals treated)
- very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
4.7 Use during pregnancy, lactation or lay
The product is specifically for use in the post-parturition period.
4.8 Interaction with other medicinal products and other forms of interaction
There is a potential antagonism between tetracyclines and antibiotics with
bactericidal action.
4.9 Amounts to be administered and administration route
Intrauterine use.
Cows:
2 g tetracycline hydrochloride / cow / day
equivalent to 1 tablet / cow /day
Treat one to three times at intervals of 1 up to 2 days.

Unlimited Renewal: December 2022
AN: 02355/2022
4.10 Overdose (symptoms, emergency procedures, antidotes), if necessary
Overdose is not expected because each tablet represents a single dose. Please refer
to section 4.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.